tradingkey.logo
tradingkey.logo
Suchen

iRhythm Technologies Inc

IRTC
Zur Watchlist hinzufügen
123.540USD
+4.590+3.86%
Trading geöffnet ETKurse um 15 Minuten verzögert
4.06BMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über iRhythm Technologies Inc Unternehmen

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.

iRhythm Technologies Inc Informationen

BörsenkürzelIRTC
Name des UnternehmensiRhythm Technologies Inc
IPO-datumOct 20, 2016
CEOBlackford (Quentin S)
Anzahl der mitarbeiter2000
WertpapierartOrdinary Share
GeschäftsjahresendeOct 20
Addresse699 8th Street
StadtSAN FRANCISCO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94103
Telefon14156325700
Websitehttps://www.irhythmtech.com/
BörsenkürzelIRTC
IPO-datumOct 20, 2016
CEOBlackford (Quentin S)

Führungskräfte von iRhythm Technologies Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
120.88K
+0.15%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
40.03K
-4.29%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
26.55K
+0.52%
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
23.03K
-17.10%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
20.51K
+7.67%
Mr. Bruce G. Bodaken
Mr. Bruce G. Bodaken
Independent Director
Independent Director
12.85K
+12.24%
Mr. Daniel G. (Dan) Wilson
Mr. Daniel G. (Dan) Wilson
Chief Financial Officer
Chief Financial Officer
12.26K
-35.00%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+11.86%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
9.78K
+16.08%
Dr. Cathleen Noel Bairey Merz, M.D.
Dr. Cathleen Noel Bairey Merz, M.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
120.88K
+0.15%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
40.03K
-4.29%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
26.55K
+0.52%
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
23.03K
-17.10%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
20.51K
+7.67%
Mr. Bruce G. Bodaken
Mr. Bruce G. Bodaken
Independent Director
Independent Director
12.85K
+12.24%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von iRhythm Technologies Inc?

Die fünf größten Anteilseigner von iRhythm Technologies Inc sind: Mr. Quentin S. Blackford

Wie viele Institutionen halten Anteile an iRhythm Technologies Inc (IRTC)?

Mit Stand vom 2026Q1 halten 673 Institutionen Anteile an iRhythm Technologies Inc, mit einem Gesamtmarktwert von etwa 35.19M, was 107.08% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -2933991.00 gestiegen.

Was ist die größte Einnahmequelle von iRhythm Technologies Inc?

Am 2026Q1 erzielte das Geschäft mit Commercial Payors für iRhythm Technologies Inc den höchsten Umsatz in Höhe von 392.23M, was 52.50% des Gesamtumsatzes entspricht.